Neuropeptide Y inhibits relaxation of guinea pig cerebral, coronary, and uterine arteries: blockade by D-myo-inositol-1,2,6-triphosphate
- PMID: 1279294
- DOI: 10.1097/00005344-199209000-00019
Neuropeptide Y inhibits relaxation of guinea pig cerebral, coronary, and uterine arteries: blockade by D-myo-inositol-1,2,6-triphosphate
Abstract
Interactions between neuropeptide Y and perivascular vasodilator agents were studied in guinea pig cerebral, coronary, and uterine arteries. In all three types of arteries, vessel segments precontracted with prostaglandin F2 alpha or histamine relaxed concentration dependently upon application of acetylcholine (ACh), substance P (SP), and vasoactive intestinal peptide (VIP). Neuropeptide Y (NPY: 10(-8)-10(-7) M) caused inhibition of relaxations produced by ACh, SP, and VIP in all three types of segments; however, the effective concentration varied between vessel type. Thus, cerebral and uterine arteries were approximately 10 times more sensitive to NPY than the coronary artery. D-myo-inositol-1,2,6-triphosphate (PP56) was a potent inhibitor of the NPY effect in all three vessel types. Thus, NPY, which is colocalized not only with norepinephrine in sympathetic perivascular fibers but also with VIP and ACh in some parasympathetic neurons, can greatly reduce the vasodilatory effect of ACh and VIP, as well as of the sensory peptide SP. This further illustrates the complex interactions NPY has with perivascular neuroeffector mechanisms.
Similar articles
-
Neuropeptide Y antagonistic properties of D-myo-inositol-1.2.6-trisphosphate in guinea pig basilar arteries.Neuropeptides. 1990 Oct;17(2):99-105. doi: 10.1016/0143-4179(90)90056-5. Neuropeptides. 1990. PMID: 2280824
-
Relation between cyclic GMP generation and cerebrovascular reactivity: modulation by NPY and alpha-trinositol.Pharmacol Toxicol. 1995 Jul;77(1):48-56. doi: 10.1111/j.1600-0773.1995.tb01913.x. Pharmacol Toxicol. 1995. PMID: 8532612
-
Pertussis toxin attenuates postsynaptic actions of neuropeptide Y on the guinea-pig uterine artery.Eur J Pharmacol. 1991 Oct 15;203(2):275-81. doi: 10.1016/0014-2999(91)90724-5. Eur J Pharmacol. 1991. PMID: 1800121
-
D-myo inositol 1,2,6, triphosphate (alpha-trinositol, pp56): selective antagonist at neuropeptide Y (NPY) Y-receptors or selective inhibitor of phosphatidylinositol cell signaling?Gen Pharmacol. 1998 Nov;31(5):689-96. doi: 10.1016/s0306-3623(98)00099-8. Gen Pharmacol. 1998. PMID: 9809464 Review.
-
Neuropeptide Y in sympathetic co-transmission: recent advances in the search for neuropeptide Y antagonists.Pharmacol Toxicol. 1994 Apr-May;74(4-5):193-201. doi: 10.1111/j.1600-0773.1994.tb01098.x. Pharmacol Toxicol. 1994. PMID: 8090686 Review.
Cited by
-
Effects of neuropeptide Y and vasoactive intestinal peptide on human venous smooth muscle in vivo.Naunyn Schmiedebergs Arch Pharmacol. 1994 Aug;350(2):194-200. doi: 10.1007/BF00241096. Naunyn Schmiedebergs Arch Pharmacol. 1994. PMID: 7990977
-
Effects of chronic infusions of alpha-trinositol on regional and cardiac haemodynamics in conscious rats.Br J Pharmacol. 1994 Sep;113(1):129-36. doi: 10.1111/j.1476-5381.1994.tb16184.x. Br J Pharmacol. 1994. PMID: 7812602 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous